FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1884032213> ?p ?o ?g. }

• W1884032213 endingPage "1477" @default.
• W1884032213 startingPage "1471" @default.
• W1884032213 abstract "Thirty-one patients with small-cell lung cancer (SCLC) were treated with VP-16 and cisplatin as first-line therapy. In the majority of cases an Adriamycin (Adria Laboratories, Columbus, Ohio) containing regimen was contraindicated because of severe cardiac or hepatic disease. Eight patients who presented with cerebral metastases were also included in the series. Eleven patients had limited disease (LD), and 20 had extensive disease (ED). Of the 28 evaluable patients, 12 (43%) achieved a complete response (CR) and 12 (43%) had a partial response (PR). Four patients (14%) either had no response or progressed on treatment. The median duration of response for patients with LD was 39 weeks and for those with ED, 26 weeks. The median survival time (MST) for the whole group of responding (CR and PR) LD patients was 70 weeks (range, 28 to 181 + weeks), and for responding ED patients, it was 43 weeks (range, 17 to 68 weeks). Gastrointestinal toxicity was mild, but leukopenia and thrombocytopenia were common. There were four febrile episodes during periods of drug-induced neutropenia and this led to one treatment-related death. Nephrotoxicity occurred in 15 patients and required discontinuation of cisplatin in two. These results compare favorably with reports of standard induction chemotherapy regimens and provide further evidence of the activity of the VP-16 and cisplatin regimen in patients with SCLC." @default.
• W1884032213 created "2016-06-24" @default.
• W1884032213 creator A5007824491 @default.
• W1884032213 creator A5021420706 @default.
• W1884032213 creator A5031200997 @default.
• W1884032213 creator A5075347427 @default.
• W1884032213 creator A5080238562 @default.
• W1884032213 creator A5085252648 @default.
• W1884032213 date "1985-11-01" @default.
• W1884032213 modified "2023-10-17" @default.
• W1884032213 title "VP-16 and cisplatin as first-line therapy for small-cell lung cancer." @default.
• W1884032213 cites W135486820 @default.
• W1884032213 cites W1804144071 @default.
• W1884032213 cites W1962075013 @default.
• W1884032213 cites W1983876323 @default.
• W1884032213 cites W1984795449 @default.
• W1884032213 cites W1986626102 @default.
• W1884032213 cites W1999280354 @default.
• W1884032213 cites W2000145976 @default.
• W1884032213 cites W2010404665 @default.
• W1884032213 cites W2046385603 @default.
• W1884032213 cites W2052891914 @default.
• W1884032213 cites W2076668534 @default.
• W1884032213 cites W2273462484 @default.
• W1884032213 cites W2394860770 @default.
• W1884032213 cites W2399389630 @default.
• W1884032213 cites W2412843323 @default.
• W1884032213 cites W2413853954 @default.
• W1884032213 cites W2416444589 @default.
• W1884032213 cites W2416450954 @default.
• W1884032213 cites W2423635603 @default.
• W1884032213 cites W2431528251 @default.
• W1884032213 cites W2480785262 @default.
• W1884032213 cites W850470413 @default.
• W1884032213 doi "https://doi.org/10.1200/jco.1985.3.11.1471" @default.
• W1884032213 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/2997406" @default.
• W1884032213 hasPublicationYear "1985" @default.
• W1884032213 type Work @default.
• W1884032213 sameAs 1884032213 @default.
• W1884032213 citedByCount "272" @default.
• W1884032213 countsByYear W18840322132012 @default.
• W1884032213 countsByYear W18840322132013 @default.
• W1884032213 countsByYear W18840322132014 @default.
• W1884032213 countsByYear W18840322132015 @default.
• W1884032213 countsByYear W18840322132016 @default.
• W1884032213 countsByYear W18840322132017 @default.
• W1884032213 countsByYear W18840322132018 @default.
• W1884032213 countsByYear W18840322132019 @default.
• W1884032213 countsByYear W18840322132020 @default.
• W1884032213 countsByYear W18840322132021 @default.
• W1884032213 countsByYear W18840322132022 @default.
• W1884032213 countsByYear W18840322132023 @default.
• W1884032213 crossrefType "journal-article" @default.
• W1884032213 hasAuthorship W1884032213A5007824491 @default.
• W1884032213 hasAuthorship W1884032213A5021420706 @default.
• W1884032213 hasAuthorship W1884032213A5031200997 @default.
• W1884032213 hasAuthorship W1884032213A5075347427 @default.
• W1884032213 hasAuthorship W1884032213A5080238562 @default.
• W1884032213 hasAuthorship W1884032213A5085252648 @default.
• W1884032213 hasConcept C126322002 @default.
• W1884032213 hasConcept C141071460 @default.
• W1884032213 hasConcept C2776256026 @default.
• W1884032213 hasConcept C2776694085 @default.
• W1884032213 hasConcept C2777063308 @default.
• W1884032213 hasConcept C2778239845 @default.
• W1884032213 hasConcept C2778715236 @default.
• W1884032213 hasConcept C2778822529 @default.
• W1884032213 hasConcept C2778850193 @default.
• W1884032213 hasConcept C2780873365 @default.
• W1884032213 hasConcept C2781413609 @default.
• W1884032213 hasConcept C29730261 @default.
• W1884032213 hasConcept C71924100 @default.
• W1884032213 hasConcept C90924648 @default.
• W1884032213 hasConceptScore W1884032213C126322002 @default.
• W1884032213 hasConceptScore W1884032213C141071460 @default.
• W1884032213 hasConceptScore W1884032213C2776256026 @default.
• W1884032213 hasConceptScore W1884032213C2776694085 @default.
• W1884032213 hasConceptScore W1884032213C2777063308 @default.
• W1884032213 hasConceptScore W1884032213C2778239845 @default.
• W1884032213 hasConceptScore W1884032213C2778715236 @default.
• W1884032213 hasConceptScore W1884032213C2778822529 @default.
• W1884032213 hasConceptScore W1884032213C2778850193 @default.
• W1884032213 hasConceptScore W1884032213C2780873365 @default.
• W1884032213 hasConceptScore W1884032213C2781413609 @default.
• W1884032213 hasConceptScore W1884032213C29730261 @default.
• W1884032213 hasConceptScore W1884032213C71924100 @default.
• W1884032213 hasConceptScore W1884032213C90924648 @default.
• W1884032213 hasIssue "11" @default.
• W1884032213 hasLocation W18840322131 @default.
• W1884032213 hasLocation W18840322132 @default.
• W1884032213 hasOpenAccess W1884032213 @default.
• W1884032213 hasPrimaryLocation W18840322131 @default.
• W1884032213 hasRelatedWork W1542568406 @default.
• W1884032213 hasRelatedWork W1875902782 @default.
• W1884032213 hasRelatedWork W2020898191 @default.
• W1884032213 hasRelatedWork W2330271844 @default.
• W1884032213 hasRelatedWork W2364127836 @default.
• W1884032213 hasRelatedWork W2418393430 @default.

• next